Peripheral expression of RAG in human B lymphocytes in normal and pathological conditions is dependent on interleukin-6

Autoimmunity Reviews

Volumn 6, Issue 6, 2007, Pages 415-420

  Hillion, Sophie ^a   Youinou, Pierre ^a   Jamin, Christophe ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

Autoreactivity; B lymphocytes; IL 6; Recombination activating gene

Indexed keywords

ATLIZUMAB; B LYMPHOCYTE RECEPTOR; CYTOKINE; IA ANTIGEN; INTERLEUKIN 6; RAG1 PROTEIN; RAG2 PROTEIN;

B LYMPHOCYTE; CELL ACTIVITY; CELL MATURATION; CELL SPECIFICITY; GENE REARRANGEMENT; HUMAN; IMMUNE RESPONSE; PHYSICAL DISEASE BY BODY FUNCTION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE REARRANGEMENT, B-LYMPHOCYTE; GENES, IMMUNOGLOBULIN; GENES, RAG-1; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-6; MICE; NUCLEAR PROTEINS; RECEPTORS, ANTIGEN, B-CELL;

EID: 34249276754     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.01.002     Document Type: Review

References (40)

1. Oettinger M.A., Schatz D.G., Gorka C., and Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248 (1990) 1517-1523
2. Schatz D.G., Oettinger M.A., and Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 59 (1989) 1035-1048
3. Faust E.A., Saffran D.C., Toksoz D., Williams D.A., and Witte O.N. Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 177 (1993) 915-923
4. Billips L.G., Nunez C.A., Bertrand III F.E., Stankovic A.K., Gartland G.L., Burrows P.D., et al. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med 182 (1995) 973-982
5. Muraguchi A., Tagoh H., Kitagawa T., Nagata T., and Kishi H. Stromal cells and cytokines in the induction of recombination activating gene (RAG) expression in a human lymphoid progenitor cell. Leuk Lymphoma 30 (1998) 73-85
6. Han S., Zheng B., Schatz D.G., Spanopoulou E., and Kelsoe G. Neoteny in lymphocytes: RAG1 and RAG2 expression in germinal center B cells. Science 274 (1996) 2094-2097
7. Giachino C., Padovan E., and Lanzavecchia A. Re-expression of RAG-1 and RAG-2 genes and evidence for secondary rearrangements in human germinal center B lymphocytes. Eur J Immunol 28 (1998) 3506-3513
8. Hillion S., Saraux A., Youinou P., and Jamin C. Expression of RAGs in peripheral B cells outside germinal centers is associated with the expression of CD5. J Immunol 174 (2005) 5553-5561
9. Hikida M., Nakayama Y., Yamashita Y., Kumazawa Y., Nishikawa S.I., and Ohmori H. Expression of recombination activating genes in germinal center B cells: involvement of interleukin 7 (IL-7) and the IL-7 receptor. J Exp Med 188 (1998) 365-372
10. Nagafuchi H., Yoshikawa H., Takeba Y., Nara K., Miura K., Kurokawa M.S., et al. Recombination activating genes (RAG) induce secondary Ig gene rearrangement in and subsequent apoptosis of human peripheral blood circulating B lymphocytes. Clin Exp Immunol 136 (2004) 76-84
11. Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K., et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167 (1988) 332-344
12. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368 (1994) 339-342
13. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8 (2006) S2:S2
14. Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6 (1997) 315-325
15. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 90 (1993) 11924-11928
16. Mihara M., Moriya Y., Kishimoto T., and Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34 (1995) 321-325
17. Kudo O., Sabokbar A., Pocock A., Itonaga I., Fujikawa Y., and Athanasou N.A. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32 (2003) 1-7
18. Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18 (1988) 1797-1801
19. Stuart R.A., Littlewood A.J., Maddison P.J., and Hall N.D. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol 13 (1995) 17-22
20. Grisius M.M., Bermudez D.K., and Fox P.C. Salivary and serum interleukin 6 in primary Sjogren's syndrome. J Rheumatol 24 (1997) 1089-1091
21. Kitani A., Hara M., Hirose T., Harigai M., Suzuki K., Kawakami M., et al. Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol 88 (1992) 75-83
22. Nagafuchi H., Suzuki N., Mizushima Y., and Sakane T. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J Immunol 151 (1993) 6525-6534
23. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181 (1995) 839-844
24. Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., and Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147 (1991) 117-123
25. Smolen J.S., and Maini R.N. Interleukin-6: a new therapeutic target. Arthritis Res Ther 8 (2006) S2-S5
26. Maini R.N., Taylor P.C., Szechinski J., Pavelka K., Broll J., Balint G., et al. Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum 54 (2006) 2817-2829
27. Richards H.B., Satoh M., Shaw M., Libert C., Poli V., and Reeves W.H. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J Exp Med 188 (1998) 985-990
28. Finck B.K., Chan B., and Wofsy D. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J Clin Invest 94 (1994) 585-591
29. Mihara M., Takagi N., Takeda Y., and Ohsugi Y. IL-6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice. Clin Exp Immunol 112 (1998) 397-402
30. Klashman D.J., Martin R.A., Martinez-Maza O., and Stevens R.H. In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum 34 (1991) 276-286
31. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 6 (2006) 728-740
32. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., and Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science 301 (2003) 1374-1377
33. Hillion S., Rochas C., Youinou P., and Jamin C. Expression and reexpression of recombination activating genes: relevance to the development of autoimmune states. Ann N Y Acad Sci 1050 (2005) 1-9
34. Meffre E., Papavasiliou F., Cohen P., de Bouteiller O., Bell D., Karasuyama H., et al. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J Exp Med 188 (1998) 765-772
35. Li Y., Li H., and Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 195 (2002) 181-188
36. Yurasov S., Wardemann H., Hammersen J., Tsuiji M., Meffre E., Pascual V., et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 201 (2005) 703-711
37. Girschick H.J., Grammer A.C., Nanki T., Vazquez E., and Lipsky P.E. Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus. Arthritis Rheum 46 (2002) 1255-1263
38. Samuels J., Ng Y.S., Coupillaud C., Paget D., and Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med 201 (2005) 1659-1667
39. Zhang Z., Wu X., Limbaugh B.H., and Bridges Jr. S.L. Expression of recombination-activating genes and terminal deoxynucleotidyl transferase and secondary rearrangement of immunoglobulin kappa light chains in rheumatoid arthritis synovial tissue. Arthritis Rheum 44 (2001) 2275-2284
40. Hillion S., Rochas C., Devauchelle V., Youinou P., and Jamin C. Central and peripheral RAG protein re-expression: underestimate mechanisms of tolerance?. Scand J Immunol 64 (2006) 185-189